Pharmacovigilance: Opportunity and Future Career Prospects for Fresh Graduates – A Report

  • Reenu Yadav Principal IITM (Deptt of Pharmacy), IES University, Bhopal
  • Syed Ziaur Rahman Professor, Department of Pharmacology, Jawaharlal Nehru Medical College, Aligarh Muslim University, Aligarh


In India, surveillance of adverse drug reactions developed when most of the developed and some of the not so developed countries had established monitoring programme. Many of these had formed National Centers and joined hands with WHO collaborating Centre for International Drug Monitoring, being governed through Uppsala Monitoring Centre, Sweden. In 1989, Indian Council of Medical Research (ICMR) for the first time came forward to finance a multicentric ADR monitoring programme involving six medical colleges located at Aligarh, Delhi, Jhansi, Meerut and Vellore. In a span of three years, ADR data from 58,194 patients was collected and reported to ICMR. This programme was later on converted into a task force, wherein the centers were increased from 6 to 12 located at Aligarh, Delhi, Jammu, Bhopal, Baroda, Hyderabad, Vellore, Bangalore, Chennai, Kolkata, Mumbai and Guwahati. Both these multicentric studies were coordinated by Prof. K. C. Singhal.


1. SZ Rahman, History of Pharmacovigilance in India, Newsletter Ibn Sina Academy 2009; 9 (1): 14-15
2. SZ Rahman, National Symposium on Relevance of Herbal Pharmacovigilance – A Report, Newsletter Ibn Sina Academy 2007; 7 (1): 7-8
3. Ghosh NS, Gupta SP and Rahman SZ. SoPI Supported National Pharmacovigilance Conferences – A Report, J Pharmacovigilance Drug Safety 2019; 16(1): 16-21 (ISSN: 0972-8899)